Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway.
Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the...
Jin, Yingying; Xu, Kun; Chen, Qingjuan; Wang, Baofeng; Pan, Jiyuan; Huang, Shan; Wei, Yang; Ma, Hongbing
2018-10-05 00:00:00
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngExperimental Cell ResearchPubmedhttp://www.deepdyve.com/lp/pubmed/simvastatin-inhibits-the-development-of-radioresistant-esophageal-99UbAA2nlB
Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway.
Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.